Pathways to new drug discovery in neuropsychiatry.

about

Evaluating differential developmental trajectories to adolescent-onset mood and psychotic disorders.Evolution of optogenetic microdevices The diminished pipeline for medications to treat mental health and substance use disorders Translational psychiatry--light at the end of the tunnel.

P2860

Q34480242-719B4916-06DC-4F57-B072-BA7A4FD655D4 Q35782464-C5C331DD-76D2-401D-BF27-0C80DF9B66E4 Q36677600-00678517-9E32-4EE3-A0AF-78BF45D34F58 Q38370696-30DC71E2-D923-4CC8-BC41-B13D2E19E3CA

P2860

Pathways to new drug discovery in neuropsychiatry.

Item

http://www.wikidata.org/entity/Q36594394

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Pathways to new drug discovery in neuropsychiatry.

@ast

Pathways to new drug discovery in neuropsychiatry.

@en

type

Item

label

Pathways to new drug discovery in neuropsychiatry.

@ast

Pathways to new drug discovery in neuropsychiatry.

@en

prefLabel

Pathways to new drug discovery in neuropsychiatry.

@ast

Pathways to new drug discovery in neuropsychiatry.

@en

P1476

Pathways to new drug discovery in neuropsychiatry.

@en

P2860

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Animal models of neuropsychiatric disorders

Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial

Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study

Next-generation treatments for mental disorders.

Bidirectional association between depression and type 2 diabetes mellitus in women

Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.

Does dopamine dysfunction drive depression?

Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis

Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression.

P2888

1741-7015-10-151

P304

151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1741-7015-10-151

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Berk

P577

2012-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233803259

http://www.w3.org/2001/XMLSchema#string

P6179

1051240645

http://www.w3.org/2001/XMLSchema#string

P698

23194414

http://www.w3.org/2001/XMLSchema#string

P932

3566919

http://www.w3.org/2001/XMLSchema#string

Pathways to new drug discovery in neuropsychiatry.

about

P2860

P2860

Pathways to new drug discovery in neuropsychiatry.

description

name

type

label

prefLabel

P1433

P1476

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P932